Pancreatic Cancer and Tumor

When aberrant pancreatic cells proliferate unchecked and develop into a tumor, pancreatic cancer begins. The exocrine and endocrine cell types both of which are present in the pancreas and perform a variety of tasks, are both present. Exocrine tumors are thought to account for about 94% of pancreatic cancer cases. The exocrine cells that produce pancreatic enzymes, which aid in digesting, are where the tumors first appear. In this category, adenocarcinomas make up the majority of tumors. The percentage of pancreatic neuroendocrine tumors is approximately 6%. Surgery, chemotherapy, radiation therapy, or a combination of these therapies may all be used to treat pancreatic cancer.
 
Prevention-
 
Stop smoking
Maintain a healthy weight
Choose a healthy diet

    Related Conference of Pancreatic Cancer and Tumor

    June 04-05, 2025

    25th International Conference on Gastroenterology and Hepatology

    Edinburgh, Scotland
    July 07-08, 2025

    20th Euro-Global Gastroenterology Conference

    Zurich, Switzerland
    July 28-29, 2025

    31st World Conference on Gastroenterology & Hepatology

    Dubai, UAE
    July 30-31, 2025

    16th International Conference on Liver Diseases & Hepatology

    Paris, France
    July 30-31, 2025

    4th International Conference on Gastroenterology and Liver

    Paris, France
    August 21-22, 2025

    6th Global Summit on Earth Science and Climate Change

    Paris, France
    August 21-22, 2025

    17th World Conference on Gynecology, Obstetrics and Women Health

    London, UK
    August 27-28, 2025

    13th World Gastro Summit

    Paris, France
    September 29-30, 2025

    7th International Conference on Gastroenterology and Liver Diseases

    Paris, France
    October 20-21, 2025

    24th International Conference on Gastroenterology and Digestive Disorders

    Osaka, Japan

    Pancreatic Cancer and Tumor Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in